Cargando…

Characterization of Induced Neural Progenitors from Skin Fibroblasts by a Novel Combination of Defined Factors

Recent reports have demonstrated that somatic cells can be directly converted to other differentiated cell types through ectopic expression of sets of transcription factors, directly avoiding the transition through a pluripotent state. Our previous experiments generated induced neural progenitor-lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Changhai, Liu, Qiang, Ma, Kangmu, Wang, Yongxiang, Chen, Qiang, Ambroz, Randall, Klinkebiel, David L., Li, Yuju, Huang, Yunlong, Ding, Jianqing, Wu, Jie, Zheng, Jialin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581826/
https://www.ncbi.nlm.nih.gov/pubmed/23439431
http://dx.doi.org/10.1038/srep01345
Descripción
Sumario:Recent reports have demonstrated that somatic cells can be directly converted to other differentiated cell types through ectopic expression of sets of transcription factors, directly avoiding the transition through a pluripotent state. Our previous experiments generated induced neural progenitor-like cells (iNPCs) by a novel combination of five transcription factors (Sox2, Brn2, TLX, Bmi1 and c-Myc). Here we demonstrated that the iNPCs not only possess NPC-specific marker genes, but also have qualities of primary brain-derived NPCs (WT-NPCs), including tripotent differentiation potential, mature neuron differentiation capability and synapse formation. Importantly, the mature neurons derived from iNPCs exhibit significant physiological properties, such as potassium channel activity and generation of action potential-like spikes. These results suggest that directly reprogrammed iNPCs closely resemble WT-NPCs, which may suggest an alternative strategy to overcome the restricted proliferative and lineage potential of induced neurons (iNCs) and broaden applications of cell therapy in the treatment of neurodegenerative disorders.